Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 1/28/2025China's Evolving Role in Pharma Spurs Regional Realignments, Boosts In...
  • 1/28/2025InnoCare's Efsubaglutide Alfa Receives Approval in China for Type 2 Di...
  • 1/28/2025CStone Partners with SteinCares to Market Sugemalimab in Latin America
  • 1/27/2025AsiFlyer Secures Series Pre-A++ Funding to Advance Botulinum Toxin Dru...
  • 1/27/2025GeneQuantum Announces Strategic Collaborations with Biohaven and Aimed...
  • 1/27/2025Lumiere Secures Series Pre-A Funding to Advance Gene Editing Research
  • 1/24/2025Ab&B Biotech Submits IPO Application to Hong Kong Stock Exchange
  • 1/24/2025Hengrui's Insulin Degludec BLA Accepted by China's NMPA
  • 1/23/2025TargetRx Secures $50 Million in Series C Financing to Propel Global Cl...
  • 1/23/2025Belief BioMed Announces IND Clearance by FDA for DMD Gene Therapy Cand...
  • 1/22/2025Degron Secures $20M in Series A+ Financing to Advance Molecular Glue T...
  • 1/22/2025Imbioray Secures Series A+ Financing to Advance NK Cell Therapy Pipeli...
  • 1/22/2025Fosun Pharma’s Bid to Privatize Henlius Fails After Shareholder Rejec...
  • 1/22/2025Shanghai Bao Pharma Files for IPO on HKSE
  • 1/22/2025Qyuns Thera Secures CSRC Approval for Full H-share Circulation
  • 1/21/2025China's Biopharma R&D Expands Global Influence in 2024
  • 1/21/2025ArriVent Enters Exclusive License with Lepu Biopharma for MRG007, an A...
  • 1/21/2025Sichuan Biokin Refiles for Hong Kong IPO Following Lapsed Application
  • 1/21/2025 China-based Ascentage Pharma Targets $149M in US IPO
  • 1/21/2025Fermion and Simcere Join Forces to Develop Non-Opioid Analgesic 
  • 1/21/2025IVIEW Thera Completes Series A++ Financing to Advance Ophthalmology Pi...
  • 1/20/2025JOINN Biologics Acquires Lonza's Large Molecule CDMO Facility in Guang...
  • 1/20/2025InnoCare and KeyMed Jointly Enter License Deal with Prolium for CD20xC...
  • 1/20/2025Junshi and LEO Enter Commercialization Partnership for Toripalimab in ...
  • 1/20/2025InflamaX Secures Pre-A Investment for Immuno-Inflammatory Research  
  • 1/17/2025Simnova and Orna Expand Partnership to Include BCMA-Targeted RNA Thera...
  • 1/17/2025Bivision Secures ~CNY 100M in Series A+ Financing, Accelerates Targete...
  • 1/16/2025Hengrui Pharma Poised for Global Expansion, Eyes More Deals
  • 1/16/2025Menarini and Insilico Forge Strategic Partnership to Address Unmet Nee...
  • 1/16/2025Conjustar Biotech Completes CNY 100M Series Pre-A+ Financing
  • Page:6/21 Total number of articles:630: [First][<<] [4] [5] [6] [7] [8] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group